HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brivanib and FOLFOX in hepatocellular carcinoma: finding the common themes among negative trials.

AuthorsRobin K Kelley
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 31 Issue 28 Pg. 3483-6 (Oct 01 2013) ISSN: 1527-7755 [Electronic] United States
PMID23980088 (Publication Type: Editorial, Comment)
Chemical References
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Triazines
  • Niacinamide
  • Sorafenib
  • brivanib
  • Alanine
Topics
  • Alanine (analogs & derivatives, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy)
  • Drug Resistance, Neoplasm (drug effects)
  • Female
  • Humans
  • Liver Neoplasms (drug therapy)
  • Male
  • Niacinamide (adverse effects, analogs & derivatives, therapeutic use)
  • Palliative Care
  • Phenylurea Compounds (adverse effects, therapeutic use)
  • Protein Kinase Inhibitors (adverse effects, therapeutic use)
  • Salvage Therapy
  • Sorafenib
  • Triazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: